Phase II study evaluating lapatinib in combination with nab-paclitaxel in HER2-overexpressing metastatic breast cancer patients who have received no more than one prior chemotherapeutic regimen
Titel:
Phase II study evaluating lapatinib in combination with nab-paclitaxel in HER2-overexpressing metastatic breast cancer patients who have received no more than one prior chemotherapeutic regimen
Auteur:
Yardley, Denise A. Hart, Lowell Bosserman, Linda Salleh, Mansoor N. Waterhouse, David M. Hagan, Maura K. Richards, Paul DeSilvio, Michelle L. Mahoney, Janine M. Nagarwala, Yasir